Johnson & Johnson Joins Other Companies in Signing a Landmark Communiqué on Expanded Global Access for COVID-19

Fri, 10/02/2020 - 12:30

In signing the communiqué, Johnson & Johnson and 15 other life science companies are committing to prioritize the safety, science and accessibility of the potential vaccines, therapeutic medicines or diagnostic tools they are developing to help fight the pandemic.

Aflac Contributes $1.5 Million to Sickle Cell Disease Program at the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta

Tue, 10/06/2020 - 10:30

September is National Sickle Cell Awareness Month, and Aflac, a leader in supplemental insurance sales at U.S. worksites, today announced the company's 2020 annual contribution of $1.5 million to the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta has been earmarked for the hospital's Sickle Cell Disease Program.

[WEBINAR] Reimagining Community Health Systems: Join SAP, Medtronic Foundation, and Leading Nonprofits in Community Health (Thurs, 10/15, 12 - 1 EDT)

Wed, 09/30/2020 - 16:30

Come get a glimpse of how the world can be reimagined toward a much stronger future with your help.

New Sensory Room at New Hope Middle School 'a Safe Space' for Special Needs Students

Wed, 09/30/2020 - 16:35

New Hope Middle School officially opened its new Kodiak Calming Cove, a sensory room for children with special needs, recently, and "it'll make a big difference for students to have a safe space they can go into," said Belinda Sloan, the school's principal.

Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate

Mon, 09/28/2020 - 16:35

Johnson & Johnson (NYSE: JNJ) (the Company) recently announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies.

Factories, Face Masks and the New Back To School

Tue, 09/29/2020 - 12:00

Merck for Mothers Ambassador Keelee Moseley Shares Maternal Health Journey

Fri, 09/25/2020 - 15:30

The Next Phase of Our COVID-19 Vaccine Development

Tue, 09/29/2020 - 12:30

We’re pleased to announce that based on interim results from our ongoing studies, the Janssen Pharmaceutical Companies of Johnson & Johnson are launching ENSEMBLE, a large-scale, multi-country Phase 3 trial of a single dose of our vaccine candidate.

Reimagining Community Health Systems Challenge to Deliver Telehealth to Underserved Areas Ends With Strategies for Expansion

Wed, 09/23/2020 - 14:05

PYXERA Global’s Reimagining Community Health Systems Challenge ended in September with U.S. Community Health Centers poised to play a stronger role in expanding telehealth services for 30 million low-income patients

4 High-Tech Tools Johnson & Johnson Is Using to Get Products to You During the Pandemic

Tue, 09/22/2020 - 14:30

While consumers were getting a crash course in supply and demand, the experts at Johnson & Johnson remained confident in their ability to manage or circumvent disruptions so that hospitals, pharmacies and people around the world could continue to get much needed medications, medical devices and other healthcare products.